ISRG - Company ID 0001035267
The table below shows INTUITIVE SURGICAL INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $3.03B | $2.42B | $1.81B | $1.49B | $2.09B | $1.48B |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | $665.80M | -$3.27B | -$360.10M | $1.37B | -$2.46B | -$940.60M |
| Dividends paid | - | - | - | - | - | - |
INTUITIVE SURGICAL INC reported operating cash flow of $3.03B for fiscal year 2025. That is up 25.5% from $2.42B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.09B (FY 2016) to $3.03B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $2.30B | $0.00 | $416.30M | $2.61B | $0.00 | $134.30M |
| Financing cash flow | -$2.36B | $150.90M | -$287.60M | -$2.57B | $43.00M | -$85.70M |